Subscribe to Newsletter

Drug Discovery

Discovery & Development Drug Discovery

The Microbiome Miner

| Angus Stewart | 9 min read

Water is the giver of life, but could it be a giver of untold medicines too?

Discovery & Development Clinical Trials

Positive Opinion for Regeneron’s Libtayo

| Rob Coker | 3 min read

Regeneron Pharmaceuticals’ Israel Lowy explains how a positive CHMP opinion can become good news for cancer patients

Discovery & Development Drug Discovery

Fresh Hope for ADC Development

| Rob Coker | 6 min read

Historic challenges in ADC Development have not thwarted some players

Discovery & Development Drug Discovery

D is for Decolonize: Sitting Down With Luis Pizarro

| Angus Stewart | 10 min read

The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world

Discovery & Development Drug Discovery

Bacteria to the Future

| Rob Coker | 2 min read

AMR remains a pressing issue, but hydroquinine has yielded some interesting effects on clinically important bacteria

Discovery & Development Drug Discovery

The End of Alopecia?

| Robyn Goforth | 3 min read

Insights into the quest to find an effective treatment for this socially painful condition

Discovery & Development Drug Discovery

The World Versus Leishmaniasis

| Fabiana Alves | 7 min read

How global collaborations are inching us toward a victory over a neglected parasitic disease

Discovery & Development Drug Discovery

Discovery, Danger, and Duality

| Angus Stewart | 7 min read

Can AI usher in a new age of medicine or is it all hype? In this blog, we go down the rabbit hole.

Discovery & Development Formulation

Veranova: Leading the Way in Synthetic Chemistry

| Sponsored by Veranova | 4 min read

As new treatment modalities emerge, drug developers are turning to synthetic chemistry – and partners like Veranova.

Manufacture Vaccines

“Could You Patent the Sun?” – Jonas Salk, Albert Sabin, and the Polio Vaccine

| Angus Stewart | 18 min read

How two rival projects relate to a modern disease landscape threatened by climate change and low vaccination rates

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register